[13C6]-Pralatrexate triglutamate
Catalog Number |
ACMA00065212 |
Description |
Pralatrexate triglutamate is intended for Pharmaceuticals applications. Pralatrexate is indicated for the treatment of relapsed or refractory peripheral T-cell lymphoma. All information about [13C6]-Pralatrexate triglutamate is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. |
Molecular Weight |
741.67 |
Molecular Formula |
C2713C6H37N9O11 |
Purity |
≥98% |
Isotopic Enrichment |
99% 13C |
Stability |
≥1 year |
Please kindly note that our products and services are for research use only.